Cargando…
Promising Performance of 4HMS, a New Zirconium-89 Octadendate Chelator
[Image: see text] Over the last decade, the interest in zirconium-89 ((89)Zr) as a positron-emitting radionuclide increased considerably because of its standardized production and its physical half-life (78.41 h), which matches the biological half-life of antibodies and its successful use in preclin...
Autores principales: | Alnahwi, Aiman H., Ait-Mohand, Samia, Dumulon-Perreault, Véronique, Dory, Yves L., Guérin, Brigitte |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7240819/ https://www.ncbi.nlm.nih.gov/pubmed/32455192 http://dx.doi.org/10.1021/acsomega.0c00207 |
Ejemplares similares
-
[(68)Ga]Ga-4HMSA a promising new PET tracer for imaging inflammation
por: Kahn Ali, Shigufa, et al.
Publicado: (2021) -
Comparative study of (64)Cu/NOTA-[D-Tyr(6),βAla(11),Thi(13),Nle(14)]BBN(6-14) monomer and dimers for prostate cancer PET imaging
por: Fournier, Patrick, et al.
Publicado: (2012) -
Recent Advances in Zirconium-89 Chelator Development
por: Bhatt, Nikunj B., et al.
Publicado: (2018) -
The Race for Hydroxamate-Based Zirconium-89 Chelators
por: Feiner, Irene V. J., et al.
Publicado: (2021) -
PACE4-Based Molecular Targeting of Prostate Cancer Using an Engineered (64)Cu-Radiolabeled Peptide Inhibitor()()
por: Couture, Frédéric, et al.
Publicado: (2014)